Dongguan HEC Biopharmaceutical R&D Co., Ltd. clinical trials

A subsidiary of Sunshine Lake Pharma Co., Ltd.

The registry lists 3 studies whose lead sponsor is Dongguan HEC Biopharmaceutical R&D Co., Ltd.. 0 are recruiting or about to start. Per ClinicalTrials.gov, last updated Apr 29, 2025.

Status

Completed: 3

Phase

Phase 1: 2
Phase 2: 1

Where

China: 2
Australia: 1

Registry sponsor names on this page

Dongguan HEC Biopharmaceutical R&D Co., Ltd.3 studies

Something wrong with this grouping? Tell us on the Sunshine Lake Pharma Co., Ltd. page.

Studies

Recruiting first, then most recently updated. Showing 3 of 3. All Sunshine Lake Pharma Co., Ltd. studies →

Phase 2 Study of HEC88473 Injection in Subjects With Type 2 Diabetes MellitusCompletedNCT06148649Phase 2
Sponsor listed in the registry: Dongguan HEC Biopharmaceutical R&D Co., Ltd.
A Phase 1 Study of HEC88473 Injection in Healthy Subjects, Obese Subjects and T2DM SubjectsCompletedNCT05943886Phase 1
Sponsor listed in the registry: Dongguan HEC Biopharmaceutical R&D Co., Ltd.
The Safety, Tolerability, Pharmacokinetic, and Pharmacodynamic Study of HEC88473 in Healthy SubjectsCompletedNCT04829123Phase 1
Sponsor listed in the registry: Dongguan HEC Biopharmaceutical R&D Co., Ltd.